
OLBA HEALTHCARE HOLDINGS, Inc.
2689.TJPXHealthcareMedical - Distribution
Latest quote
¥1,871
−¥4.00 · -0.21%
2689.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteOLBA HEALTHCARE HOLDINGS, Inc., founded in 1921 and based in Okayama, Japan, provides an extensive range of healthcare and life science solutions to a diverse clientele across the country. Its customers include medical facilities, academic institutions, corporate research laboratories, individuals, and elderly care providers. The company's operations span several key areas. Its Medical Equipment business acts as a wholesale distributor for a wide array of advanced medical devices. This includes prosthetic and implantable items such as artificial joints, pacemakers, and coronary stents; surgical tools like steel instruments and ultrasonic scalpels; and diagnostic imaging systems such, as MRI and CT scanners. Additionally, they supply essential hospital equipment, including respirators, intraoperative monitors, and surgical lighting. In the realm of life sciences, OLBA HEALTHCARE offers specialized reagents and apparatus for genetic research, cell culture, and protein analysis. They also provide automated analyzers for biochemistry, immunology, and blood diagnostics, along with various testing reagents. Furthermore, the company performs dedicated DNA analysis services. The Supply Processing and Distribution (SPD) business supports clients by managing inventory, information, and procurement functions efficiently. Finally, the Nursing Care Products business focuses on enhancing the well-being of those requiring care. This segment offers rental services for nursing care equipment and sells welfare aids such as portable toilets and bathing solutions. They are also involved in managing a program designed to facilitate comfortable long-term care at home, referred to as "long-term care reform." The company rebranded from Kawanishi Holdings, Inc. to OLBA HEALTHCARE HOLDINGS, Inc. in January 2021.
- Industry
- Medical - Distribution
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Yohei Maeshima
- Listed since
- Jan 4, 2001
- Employees
- 1,393
Market position
Day range
Current ¥1,871
52-week range
Current ¥1,871
- Open
- ¥1,875
- Previous close
- ¥1,875
- Volume
- 2.3K
- 0.47× average
- Average volume
- 4.86K
- Average daily volume
- Market cap
- 11.09B JPY
- Beta
- 0.26
- Market reference 1
- 50-day average
- ¥1,931.68
- -3.14% below average
- 200-day average
- ¥2,042.69
- -8.40% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 11.52B JPY
- P/E (TTM)
- 9.97×
- P/B (TTM)
- 0.85×
- P/S (TTM)
- 0.09×
- EV / EBITDA
- 4.75×
- Earnings yield
- 9.87%
- Free cash flow yield
- -3.45%
- Dividend yield
- 4.28%
Profitability & efficiency
- Gross margin
- 11.20%
- Operating margin
- 1.33%
- Net margin
- 0.88%
- Return on equity
- 8.52%
- Return on assets
- 2.38%
- Return on invested capital
- 5.99%
Financial health
- Debt / equity
- 0.22×
- Current ratio
- 1.23×
- Altman Z-score
- 3.58
- Piotroski F-score
- 3 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 126.6B JPY | 122.7B JPY | 118.56B JPY | 110.47B JPY | 107.96B JPY |
| Cost of goods sold | 112.42B JPY | 108.79B JPY | 104.96B JPY | 97.52B JPY | 95.46B JPY |
| Gross profit | 14.18B JPY | 13.91B JPY | 13.6B JPY | 12.95B JPY | 12.5B JPY |
| Selling, general, and administrative | 12.5B JPY | 11.93B JPY | 11.37B JPY | 10.81B JPY | 10.43B JPY |
| Operating expenses | 12.5B JPY | 11.93B JPY | 11.37B JPY | 10.8B JPY | 10.43B JPY |
| Interest income | 2.49M JPY | 1.31M JPY | 4.03M JPY | 463K JPY | 315K JPY |
| Interest expense | 60.16M JPY | 37.68M JPY | 19.43M JPY | 17.85M JPY | 20.52M JPY |
| Depreciation and amortization | 743.21M JPY | 636.4M JPY | 564.87M JPY | 510.12M JPY | 403.45M JPY |
| Operating income | 1.68B JPY | 1.98B JPY | 2.23B JPY | 2.15B JPY | 2.07B JPY |
| Net income | 1.11B JPY | 1.43B JPY | 1.5B JPY | 1.41B JPY | 1.54B JPY |
Company facts updated Aug 25, 2026.
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
¥80.00
2025 complete year+60.0% since 2021
2026 partial: ¥80.00
¥50.00
2,021
¥60.00
2,022
¥70.00
2,023
¥80.00
2,024
¥80.00
2,025
¥80.00
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Jun 29, 2026 | ¥80.00Annual | Jun 30, 2026 | Sep 30, 2026 |
Dividend | Jun 27, 2025 | ¥80.00Annual | Jun 30, 2025 | Sep 26, 2025 |
Dividend | Jun 27, 2024 | ¥80.00Annual | Jun 30, 2024 | Sep 27, 2024 |
Dividend | Jun 29, 2023 | ¥70.00Annual | Jun 30, 2023 | Sep 29, 2023 |
Dividend | Jun 29, 2022 | ¥60.00Annual | Jun 30, 2022 | Sep 22, 2022 |
Dividend | Jun 29, 2021 | ¥50.00Special | Jun 30, 2021 | Sep 24, 2021 |
Ex-dividend Jun 29, 2026
¥80.00
Annual
Record Jun 30, 2026 · Payment Sep 30, 2026
Ex-dividend Jun 27, 2025
¥80.00
Annual
Record Jun 30, 2025 · Payment Sep 26, 2025
Ex-dividend Jun 27, 2024
¥80.00
Annual
Record Jun 30, 2024 · Payment Sep 27, 2024
Ex-dividend Jun 29, 2023
¥70.00
Annual
Record Jun 30, 2023 · Payment Sep 29, 2023
Ex-dividend Jun 29, 2022
¥60.00
Annual
Record Jun 30, 2022 · Payment Sep 22, 2022
Ex-dividend Jun 29, 2021
¥50.00
Special
Record Jun 30, 2021 · Payment Sep 24, 2021
2689.T peers
Continue in GoAI
Research 2689.Tresearch.disclaimer





